ArticleDer Nervenarzt2003
[Psychiatrists and the pharmaceutical industry].
Article in Der Nervenarzt, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- What is the impact of financial conflicts of interest on the development of psychiatry?World psychiatry : official journal of the World Psychiatric Association (WPA) · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Relationships between psychiatrists and the pharmaceutical industry have increased in frequency and intensity, both on the individual level and particularly on the institutional level. They extend from necessary and desirable cooperation to questionable practices and to unacceptable misconduct. Especially the latter has provoked a lively discussion and has initiated recommendations as well as guidelines. Their aim is to safeguard the integrity of physicians as well as the industry and to avoid endangering the relationship between the physician and the patient. They will do this by establishing clear norms, unequivocal documentation, and disclosure of relevant relationships in order to build up more mutual trust including that of the public. Based on a detailed review of the literature, 27 recommendations are put forward for discussion. Psychiatric associations should develop explicit guidelines for the relationships between psychiatrists and the pharmaceutical industry.
Indexed as
Identifiers
14694885What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.